Skip to content

EV / EBITDA at other companies

CVS Health logo
CVS HealthCVS
9.2×+2.7×
UnitedHealth Group logo
UnitedHealth GroupUNH
12.8×-1.3×
Cigna logo
CignaCI
5.5×-0.2×
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
19×+3.3×
Baxter International logo
Baxter InternationalBAX
10.3×-1.6×
Encompass Health Corporation logo
Encompass Health CorporationEHC
8.6×-2.0×

Other financials

Income statement

See full
Revenue$1.4B+1.3%
Gross profit$262.0M-0.4%
Operating income$72.5M-8.4%
Net income$45.3M-3.0%
EPS (diluted)$0.29+3.6%

Balance sheet

See full
Cash & equivalents$177.3M+3.5%
Total debt$1.3B+3.9%
Total equity$1.4B0.0%
Total assets$3.4B+2.2%

Cash flow

See full
Operating cash flow-$12.1M-67.9%
CapEx$9.0M-3.5%
Free cash flow-$21.2M-27.6%

Valuation

See full
Market cap$3.45B-27.1%

Profitability

See full
Gross margin19.2%-0.8pp
Operating margin5.8%-0.6pp
Net margin3.6%-0.5pp
FCF margin3.8%-2.9pp

Returns & leverage

See full
Return on equity15.3%-0.1pp
Debt / equity0.9×0.0×
Current ratio1.6×+0.1×

Where this comes from

Calculated from Option Care Health, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Option Care Health, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Option Care Health, Inc.'s ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Option Care Health, Inc.'s EV / EBITDA?
Option Care Health, Inc. (OPCH) reported EV / EBITDA of 13.3× in Q1 2026.
How has Option Care Health, Inc.'s EV / EBITDA changed year-over-year?
Option Care Health, Inc.'s EV / EBITDA decreased by 23.1% year-over-year, from 17.3× to 13.3×.
What is the long-term trend for Option Care Health, Inc.'s EV / EBITDA?
Over 5 years (2020 to 2025), Option Care Health, Inc.'s EV / EBITDA has grown at a -7.0% compound annual growth rate (CAGR), from 21.6× to 15×.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.